Rupatadine

3 trials 2 recruiting RRespiratory

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

2 Sponsors

12 Countries

Phase III

Phase II/III

Phase III: 2 Phase II/III: 1

Oversight events:

4 temporary halts across 1 trial

View oversight register →

Indications tested

Epidermolysis bullosa 1

Sponsors using this IMP

Inmunotek S.L. 2 Rheacell GmbH & Co. KG 1

All trials

3 total

Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Phase III 12 countries Rheacell GmbH & Co. KG
A prospective, randomized, double-blind, placebo-controlled, multicentre, dose-finding clinical trial with polymerised mannan-conjugated all… Recruiting

2025-524580-21-00 Phase II/III 1 country Inmunotek S.L.
A prospective, randomized, double-blind placebo-controlled multicentre trial with mannan-conjugated birch pollen allergoids administered sub… Ended

2024-515717-17-00 Phase III 1 country Inmunotek S.L.

Showing 1–3 of 3 trials

← All drugs A–Z